-
Phosphotungstic Acid Negative Stain Solution (2%)
2026-09-28
Phosphotungstic Acid Negative Stain Solution (2%) is a ready-to-use electron microscopy reagent that creates contrast by increasing electron density around a specimen. It can support visualization of macromolecules and microorganisms, but negative staining does not identify specific glycans or demonstrate antiviral activity. The article separates the product’s imaging role from research on conserved coronavirus spike glycans.
-
LY294002 Workflows for PI3K-Linked Cancer Biology
2026-09-27
Use LY294002 to test whether PI3K/Akt signaling contributes to cancer-cell responses, including periostin regulation in HER2-positive breast cancer models. This workflow pairs dose and timing controls with pathway, gene-expression, and viability readouts—while flagging the compound’s micromolar BET activity as an interpretation caveat.
-
VX-661 and the Next Logic of CFTR Rescue
2026-09-26
VX-661 can help researchers separate correction of F508del-CFTR trafficking from potentiation of channel activity. New evidence on calnexin-dependent CFTR expression adds a further experimental dimension: proteostasis context may influence variant response, but it should be tested rather than assumed.
-
Non-canonical ORFs Support Medulloblastoma Survival
2026-09-26
Hofman and colleagues combine ribosome profiling with CRISPR screens to show that non-canonical open reading frames are translated in medulloblastoma and can contribute to tumor-cell survival. Their work identifies the ASNSD1-uORF microprotein, ASDURF, as a survival-associated factor linked to the prefoldin-like complex, expanding the range of candidate mechanisms for follow-up in high-risk disease.
-
Concanavalin A Targets Conserved Coronavirus Glycans
2026-09-25
Guo and colleagues identify conserved, high-mannose N-linked glycans near the coronavirus spike S2′ cleavage site as a vulnerability that concanavalin A (ConA) can exploit to inhibit viral entry. Their fusion, pseudovirus, authentic-virus, biochemical, and animal experiments support a mechanism in which glycan binding obstructs spike activation, while leaving important questions about therapeutic safety and clinical relevance unresolved.
-
GW 6471 Workflows for PPARα Mechanism Studies
2026-09-25
Use GW 6471 to test whether PPARα activity contributes to exposure-linked liver and lipid phenotypes—not merely whether a pathway signature is present. This practical guide turns zebrafish PFHxS findings into controlled antagonist experiments, with dose planning, orthogonal validation, and troubleshooting for cellular metabolism and lipid homeostasis studies.
-
LY294002: PI3K Pathway Workflows and Applications
2026-09-24
Use LY294002 as a reversible PI3K pathway probe to connect early phospho-signaling changes with cell phenotypes in cancer and macrophage assays. A practical workflow pairs a dose-response pilot with viability controls and careful interpretation of its additional BET bromodomain activity.
-
IWP-2: A Wnt Production Inhibitor
2026-09-24
IWP-2 is a potent Wnt production inhibitor that targets Porcupine and can be used to investigate ligand-dependent Wnt signaling. Product information reports a 27 nM IC50 for Wnt pathway activity and describes antiproliferative effects in the gastric cancer cell line MKN28; these preclinical findings do not establish clinical efficacy.
-
Position-3 Design of GnRH Antagonists
2026-09-23
Samant and colleagues examined how replacing position 3 of degarelix with racemic 3-(2-methoxy-5-pyridyl)-alanine affected receptor antagonism and in vivo duration. The study links peptide stereochemistry to potency and pharmacological persistence, showing that the D-configured analogue retained strong in vitro activity whereas the L-configured analogue was substantially weaker and both compounds were short-acting in castrated male rats.
-
Indometacin Sodium in Remyelination Assays
2026-09-23
Indometacin Sodium Trihydrate supports both conventional inflammation assays and mechanistic remyelination workflows. Its COX-1/COX-2 activity can be paired with Wnt/β-catenin and GSK3β-oriented readouts to distinguish prostaglandin suppression from oligodendrocyte differentiation effects.
-
Optimized hiPSC Platelet Differentiation: Study Insights
2026-09-22
This 2026 study presents an optimized differentiation scheme that combines higher embryoid body input, human platelet lysate, and small-molecule control of megakaryocyte development. The protocol shortened production to 19 days, generated functional platelets at improved yield, and reduced reported costs, although further validation is needed for scale-up and clinical translation.
-
MK-0812 in MASH Monocyte Trafficking Workflows
2026-09-21
MK-0812 provides a receptor-proximal way to test whether CCR2-dependent monocyte trafficking contributes to gut–liver inflammation, complementing genetic and microbiota-based MASH models. Its human whole-blood potency and practical DMSO formulation support translational assay design from chemotaxis and flow cytometry to mouse studies.
-
EZ Cap™ Mouse IL-12 mRNA (m1Ψ) Guide
2026-09-21
EZ Cap™ Mouse IL-12 mRNA (m1Ψ) enables a cargo-first framework for studying cytokine expression, immune activation, and extrahepatic delivery. This article connects transcript chemistry with practical assay design and insights from an engineered virus-mimicking delivery study.
-
E-64 Workflows for Cysteine Protease Research
2026-09-20
E-64 provides irreversible, low-nanomolar control of cysteine proteases for active-site titration, lysosomal protease studies, and mechanistic cancer research. This guide connects purified-enzyme assays with lysosomal membrane permeabilization workflows while emphasizing controls for cell permeability, dosing, and assay interpretation.
-
Methylprednisolone: Mechanism and Bone Models
2026-09-19
Methylprednisolone is a synthetic glucocorticoid receptor agonist used in anti-inflammatory and translational research. Product data describe cytokine, chemokine, and NF-κB-related effects, while a rat study defines a glucocorticoid-induced osteonecrosis benchmark using 20 mg/kg methylprednisolone.